Joseph Gligorov

InstitutionUniversity Hospital Tenon
AddressParis
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in April 2020 and June 2020 and June 2021
    All Publications
    Bar chart showing 154 publications over 25 distinct years, with a maximum of 13 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gerotziafas GT, Catalano M, Theodorou Y, Dreden PV, Marechal V, Spyropoulos AC, Carter C, Jabeen N, Harenberg J, Elalamy I, Falanga A, Fareed J, Agathaggelou P, Antic D, Antignani PL, Bosch MM, Brenner B, Chekhonin V, Colgan MP, Dimopoulos MA, Douketis J, Elnazar EA, Farkas K, Fazeli B, Fowkes G, Gu Y, Gligorov J, Ligocki MA, Indran T, Kannan M, Kantarcioglu B, Kasse AA, Konstantinidis K, Leivano F, Lewis J, Makatsariya A, Mbaye PM, Mahé I, Panovska-Stavridis I, Olinic DM, Papageorgiou C, Pecsvarady Z, Pillon S, Ramacciotti E, Abdel-Razeq H, Sabbah M, Sassi M, Schernthaner G, Siddiqui F, Shiomura J, Slama-Schwok A, Wautrecht JC, Tafur A, Taher A, Klein-Wegel P, Zhai Z, Zoubida TM. The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper. Thromb Haemost. 2021 Aug; 121(8):992-1007. PMID: 34169495.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    2. Palich R, Veyri M, Vozy A, Marot S, Gligorov J, Benderra MA, Maingon P, Morand-Joubert L, Adjoutah Z, Marcelin AG, Spano JP, Barrière J. High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers. Ann Oncol. 2021 10; 32(10):1294-1295. PMID: 34171494.
      Citations: 6     Fields:    Translation:Humans
    3. Palich R, Veyri M, Marot S, Vozy A, Gligorov J, Maingon P, Marcelin AG, Spano JP. Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients. Ann Oncol. 2021 08; 32(8):1051-1053. PMID: 33932501.
      Citations: 13     Fields:    Translation:Humans
    4. Fenioux C, Allenbach Y, Vozy A, Salem JÉ, Maalouf G, Vieira M, Le Joncour A, Benveniste O, Saadoun D, Frère C, Campedel L, Salem P, Gligorov J, Funck-Brentano C, Cacoub P, Gougis P. [Differences of characteristics and outcomes between cancer patients and patients with no active cancer hospitalised for a SARS-CoV-2 infection]. Bull Cancer. 2021 Jun; 108(6):581-588. PMID: 33966886.
      Citations:    Fields:    Translation:HumansPHPublic Health
    5. Benusiglio PR, Korenbaum C, Vibert R, Ezenfis J, Geoffron S, Paul C, Richard S, Byrde V, Lejeune M, Guillerm E, Basset N, Lotz JP, Chabbert-Buffet N, Gligorov J, Coulet F. Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic. Eur J Med Genet. 2020 Dec; 63(12):104098. PMID: 33186762.
      Citations:    Fields:    Translation:HumansPHPublic Health
    6. Assoun S, Benderra MA, Lotz JP, Richard S, Gligorov J. Severe acute respiratory syndrome Coronavirus 2 infection in cancer population: Are patient-related symptoms helpful to track a harmful invisible? Int J Cancer. 2020 12 15; 147(12):3576-3578. PMID: 32574373.
      Citations:    Fields:    Translation:Humans
    7. Gougis P, Fenioux C, Funck-Brentano C, Veyri M, Gligorov J, Solas C, Spano JP. Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use? Eur J Cancer. 2020 09; 136:1-3. PMID: 32610172.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    8. Belkacemi Y, Grellier N, Ghith S, Debbi K, Coraggio G, Bounedjar A, Samlali R, Tsoutsou PG, Ozsahin M, Chauvet MP, Turkan S, Boussen H, Kuten A, Tesanovic D, Errihani H, Benna F, Bouzid K, Idbaih A, Mokhtari K, Popovic L, Spano JP, Lotz JP, Cherif A, To H, Kovcin V, Arsovski O, Beslija S, Dzodic R, Markovic I, Vasovic S, Stamatovic L, Radosavljevic D, Radulovic S, Vrbanec D, Sahraoui S, Vasev N, Stojkovski I, Risteski M, Freixa SV, Krengli M, Radosevic N, Mustacchi G, Filipovic M, Kerrou K, Taghian AG, Todorovic V, Geara F, Gligorov J. A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries. Eur J Cancer. 2020 08; 135:130-146. PMID: 32580130.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    9. Ceugnart L, Delaloge S, Balleyguier C, Deghaye M, Veron L, Kaufmanis A, Mailliez A, Poncelet E, Lenczner G, Verzaux L, Gligorov J, Thomassin-Naggara I. [Breast cancer screening and diagnosis at the end of the COVID-19 confinement period, practical aspects and prioritization rules: recommendations of 6 French health professionals societies]. Bull Cancer. 2020 Jun; 107(6):623-628. PMID: 32416925.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    10. Daraï E, Mathelin C, Gligorov J. Breast Cancer Management during the COVID 19 Pandemic: French Guidelines. Eur J Breast Health. 2020 Jul; 16(3):160-161. PMID: 32656513.
      Citations: 2     
    11. Gligorov J, Bachelot T, Pierga JY, Antoine EC, Balleyguier C, Barranger E, Belkacemi Y, Bonnefoi H, Bidard FC, Ceugnart L, Classe JM, Cottu P, Coutant C, Cutuli B, Dalenc F, Darai E, Dieras V, Dohollou N, Giacchetti S, Goncalves A, Hardy-Bessard AC, Houvenaeghel G, Jacquin JP, Jacot W, Levy C, Mathelin C, Nisand I, Petit T, Petit T, Poncelet E, Rivera S, Rouzier R, Salmon R, Scotté F, Spano JP, Uzan C, Zelek L, Spielmann M, Penault-Llorca F, Namer M, Delaloge S. [COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), the Société d'Imagerie de la Femme (SIFEM), the Société Française de Chirurgie Oncologique (SFCO), the Société Française de Sénologie et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)]. Bull Cancer. 2020 05; 107(5):528-537. PMID: 32278467.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    Gligorov's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (185)
    Explore
    _
    Co-Authors (190)
    Explore
    _
    Similar People (60)
    Explore
    _